Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5486664 | 0.90 | CYP19A1 (0.41) | TDP1CYP19A1CYP11B2SMN1; SMN2HTT | |
| SCHEMBL5486669 | 0.90 | CYP19A1 (0.41) | TDP1CYP19A1CYP11B2SMN1; SMN2HTT | |
| SCHEMBL5488902 | 0.82 | TDP1 (0.42) | TDP1CYP19A1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL2495862 | 0.81 | CYP19A1 (0.39) | TDP1CYP19A1CYP11B2PTGS2MEN1 | |
| SCHEMBL2501589 | 0.77 | NOX1 (0.49) | TDP1CYP19A1CYP11B2LMNAPTGS2 | |
| SCHEMBL8192034 | 0.76 | PTGS2 (0.44) | TDP1CYP19A1CYP11B2ALDH1A1CYP1A2 | |
| SCHEMBL5488897 | 0.76 | CYP19A1 (0.41) | TDP1CYP19A1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL5488894 | 0.76 | CYP19A1 (0.41) | TDP1CYP19A1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL8183837 | 0.74 | PTGS2 (0.39) | TDP1CYP19A1CYP11B2SMN1; SMN2HTT | |
| SCHEMBL4872131 | 0.73 | TDP1 (0.45) | TDP1CYP19A1CYP11B2SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598361-B1 | ORGANIC METAL COMPLEX, ELECTROLUMINESCENT MATERIAL USING THE COMPLEX AND ECTROLUMINESCENT ELEMENT USING THE COMPLEX | SEMICONDUCTOR ENERGY LAB (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-7176307-B2 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20060106211-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2006-05-18 | — | — | US | disclosed |
| US-7041390-B2 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2006-05-09 | — | — | US | disclosed |
| EP-1598361-A1 | ORGANIC METAL COMPLEX, ELECTROLUMINESCENT MATERIAL USING THE COMPLEX AND ECTROLUMINESCENT ELEMENT USING THE COMPLEX | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-20050006625-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050006625-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | HSF1, ELP1, RPL19 | TDP1 3827/4885CYP19A1 1006/4885CYP11B2 900/4885 |
| US-20060106211-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | ELP1, HSF1, EMC1 | TDP1 3277/4885CYP19A1 806/4885CYP11B2 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.